BMJ 1994;308:1180-1181 (7 May)

Editorials

Preventing incompatible transfusions

Each year in Britain 2.2 million units of red cells are transfused and perhaps four deaths due to preventable causes subsequently occur. Providers of health care and the public express most concern about the risk of infections transmitted by transfusion, particularly HIV infection, but procedural errors resulting in ABO incompatibility cause most of the deaths immediately after blood transfusion.1,2 ABO antibodies are "naturally occurring" and are present in all subjects except those of blood group AB after the first 3 to 6 months of life. Although these antibodies can cause intravascular haemolysis, with disseminated intravascular coagulation and renal failure, most incompatible transfusions are uneventful or result in minor signs and symptoms.3,4 Only about 1 in 10 ABO incompatible transfusions is fatal.2

Studies in the United States, where all deaths associated with transfusions must be reported to the Food and Drug Administration, show that patients with blood group O are most . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Alic, Y., Akpek, E. A., Donmez, A., Ozkan, S., Perfusionist, G. Y., Aslamaci, S. (2008). ABO-Incompatible Blood Transfusion and Invasive Therapeutic Approaches During Pediatric Cardiopulmonary Bypass. Anesth. Analg. 107: 1185-1187 [Abstract] [Full text]  
  • Williamson, L. M, Heptonstall, J., Soldan, K. (1996). A SHOT in the arm for safer blood transfusion. BMJ 313: 1221-1222 [Full text]  
  • Wardrop, C A J, Holland, B M, Jones, J G. (1995). Consensus on red cell transfusion. BMJ 311: 962-963 [Full text]  
Access all current jobs at BMJ Group
Whats new online at Student BMJ
Listen to the latest BMJ Interview